Shots:

• The CDC’s ACIP has voted to recommend Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) to protect adults against invasive disease and pneumonia caused by the 20 S. pneumoniae serotypes
• The ACIP has recommended one dose of Prevnar 20 for adults aged ≥65 & for ≥19yrs. with risk conditions who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown. If PCV15 is used- it should be followed by a dose of PPSV23
• On June 8- 2021- the US FDA has approved Prevnar 20 for the prevention of invasive disease and pneumonia in adults aged ≥18yrs. and Prevnar 20 is currently under EMA’s CHMP review

 Ref: Pfizer | Image: The Wall Street Journal